Welcome to our dedicated page for UFP TECHNOLOGIES SEC filings (Ticker: UFPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UFP TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UFP TECHNOLOGIES's regulatory disclosures and financial reporting.
UFP Technologies Executive Chairman Jeffrey R. Bailly reported open-market sales of an aggregate 15,695 shares of common stock on August 6–7, 2026, through indirect holdings in a trust. Reported per-share prices include $315.06 and $318.21, with some prices disclosed as weighted averages over intraday ranges. He also holds 171,200 shares directly, separate from the trust holdings for which beneficial ownership is disclaimed except for any pecuniary interest.
UFP Technologies vice president Jason Holt reported a sale of 1,100 shares of Common Stock, $.01 Par Value, on August 6, 2026, at a price of $317 per share in a sale classified as an open market or private transaction. Following this trade, Holt now directly owns 7,878 shares of UFP Technologies common stock.
UFP Technologies, Inc. reported solid growth for the quarter ended June 30, 2026. Net sales rose 15.1% to $174.0 million, driven mainly by Surfaces and Support, Cardiovascular, Infection Control, and Orthopedics sub‑markets, with organic sales growth of 12.4%. Gross margin improved to 29.3% from 28.8%, supporting operating income of $28.1 million and net income of $20.9 million, or $2.68 diluted EPS.
For the first six months of 2026, net sales increased 9.6% to $328.2 million, and net income reached $38.3 million ($4.92 diluted EPS). Cash from operations declined to $18.8 million as receivables and inventories expanded with higher volumes. Cash was $9.0 million and total debt $117.3 million under a $275 million credit facility, with a 5.0% weighted average interest rate and covenant compliance. The business remains highly concentrated, with two customers accounting for over 20% each of sales, and management notes an ongoing AJR workforce transition and a February 2026 cyber incident that has not materially impacted operations to date.
UFP Technologies, Inc. reported record second-quarter 2026 results, with net sales of $174.0 million, up 15.1% from a year earlier, and net income of $20.9 million, 21.4% higher than the 2025 period. GAAP diluted EPS was $2.68 and adjusted diluted EPS was $2.92.
Gross margin improved to 29.3%, while operating income rose 15.5% to $28.1 million and adjusted EBITDA increased 14.3% to $36.4 million. Organic sales growth was 12.4% for the quarter. Year-to-date, sales reached $328.2 million and net income $38.3 million, with adjusted EPS of $5.39.
At June 30, 2026, total assets were $681.9 million and total equity $462.4 million. Long-term debt excluding current installments was $104.8 million, and cash and cash equivalents were $9.0 million. Management noted strong MedTech growth, flat non-medical revenue, and continued investment in Dominican Republic operations.
Vanguard Capital Management reports beneficial ownership of 387,783 shares of UFP Technologies Inc common stock, representing 5.01% of the class as of June 30, 2026. Vanguard has sole voting power over 58,160 shares and sole dispositive power over all 387,783 shares, with no shared voting or dispositive power.
The position reflects securities beneficially owned, or deemed beneficially owned, by Vanguard Capital Management LLC and certain affiliated entities and business divisions, including Vanguard Asset Management Limited and Vanguard Fiduciary Trust Company. Vanguard-managed funds and accounts have rights to dividends and sale proceeds, but no other single person has an interest in more than 5% of the class.
Wasatch Advisors reports its equity position in UFP Technologies Inc common stock in Amendment No. 3 to its Schedule 13G. The firm beneficially owns 683,262 shares, representing 8.8% of the outstanding common stock. Wasatch has sole voting power over 447,320 shares and sole dispositive power over all 683,262 shares, with no shared voting or dispositive power. The reporting person is organized in Delaware, and the certification is signed by CEO Mike Yeates on July 17, 2026.
Neuberger Berman Group LLC and affiliated advisory entities report beneficial ownership of 537,038 shares of UFP Technologies, Inc. common stock, representing 6.90% of the class as of 06/30/2026, filed on a Schedule 13G. The filing shows shared voting power of 509,414 shares and shared dispositive power of 537,038 shares across Neuberger Berman entities.